Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions

European Journal of Gynaecological Oncology

Volumn 19, Issue 3, 1998, Pages 316-318

  Ayhan, A ^a,a   Tuncer, Z S ^a   Ruacan, S ^a   Yasui, W ^b   Tahara, E ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cripto; Endometrial carcinoma; Endometrial hyperplasia; p53

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN P53;

ARTICLE; CANCER STAGING; CARCINOGENESIS; DISEASE COURSE; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; ONCOGENE; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

CARCINOMA; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031894047     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Morrow C. P., Bundy B. N., Kurman R. J., Creasman W, T., Heller P., Homesley H. D , Graham J. E.: "Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study". Gynecol. Oncol., 1991, 40, 55.
2. Baker V.: "Oncogenes in gynecologic malignancy". Current opinion in obstetrics and gynecology. 1992, 4, 75.
3. Ciccodicola A., Dono R., Obici S., Simeone A , Zollo M., Persico M. G.: "Molecular characterization of a gene of the EGF family expressed in undifferentiated human NTERA 2 teratocarcinoma cells". EMBOJ, 1989, 8, 1987
4. Qi C. F., Liscia D. S., Normanno N., Merlo G., Johnson G. R., Gullick W. J., Ciardiello F., Saeki T., Brandt R., Kim N., Kenney N., Salomon D. S.: "Expression of transforming growth factor α . amphiregulin and cripto-1 in human breast carcinomas". Br. J Cancer, 1994, 69, 903.
5. Saeki T., Salomon D , Normanno N . Johnson G. R., Gullick W. J., Mandai K., Moriwaki S., Takashima S., Kuniyasu M., Tahara E., Kawamim H., Nishiyama M., Toge T.: "Immunohistochemical detection of cripto-1, amphiregulin and transforming growth factor alpha in human gastric carcinomas and intestinal metaplasias". Int. J. Oncol., 1994, 5, 215.
6. Saeki T., Salomon D., Gullick W. J., Mandai K., Yamagami K., Moriwaki S., Takashima S., Nishikawa Y., Tahara E.: "Expression of cripto-1 in human colorectal adenomas and carcinomas is related to the degree of dysplasia". Int. J. Oncol , 1994, 5, 445.
7. Friess H., Yamanaka Y., Büchler M., Kobrin M. S., Tahara E., Korch M.: "Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis". Int. J. Cancer, 1994, 56, 668.
8. Kohler M. F., Kerns B. M., Humphrey P A., Marks J. R., Bast R. C., Berhuck A.: "Mutation and overexpression of p53 in early stage epithelial ovarian cancer". Obstet. Gynecol., 1993, 81(5), 643.
9. Kohler M. F., Berchuck A., Davidoff A. M., Humphrey P. A., Dodge R. K., Iglehart J. D.: "Overexpression and mutation of p53 in endometrial carcinoma". Cancer Res., 1992, 52, 1622.
10. Bur M. E., Perlman C., Edelmann L., Fey E., Rose P. G.: "p53 expression in neoplasms of the uterine corpus". Am. J. Clin. Pathol., 1992, 98, 81.
11. Salomon D. S., Kim N., Saeki T., Ciardiello: "Transforming growth factor x; an oncodevelopment growth factor". Cancer Cells, 1990, 2, 389.
12. Birmelin G., Zimmer V.: "Relationship between epidermal growth factor receptor and various prognostic factors in human endometrial carcinoma". Int. J. Gynecol. Cancer, 1992, 2, 66.